Showing Results for: “diabetes”

New research shows that daily oral vitamin D supplementation does not effectively reduce the risk of type 2 diabetes among vitamin D-sufficient adults at high risk for developing the disease, according to the “The Vitamin D and Type 2 Diabetes (D2d) Study – A Multicenter Randomized Controlled Trial for Diabetes Prevention” study presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco. More than 84 million Americans have prediabetes, which is a precursor of symptoms indicating higher risk of progression to type

American Diabetes Association (ADA) Pathway to Stop Diabetes® grant recipients Michael L. Stitzel, PhD, of the Jackson Laboratory, Stephen C.J. Parker, PhD, of the University of Michigan, and Praveen Sethupathy, PhD, of Cornell University, recently embarked on a collaborative research initiative empowered by the ADA Pathway to Stop Diabetes program. Bringing together diverse areas of expertise, their collaboration led to today’s report that establishes new detail about the genetic signatures of the cells that produce and release insulin, pancreatic beta (β) cells. The research, detailed in the

Hoy, la Asociación Americana de Diabetes ® (ADA, por sus siglas en inglés) publicó sus anualmente esperados Estándares de Atención Médica en Diabetes (Estándares de Atención). Basado en las últimas investigaciones científicas y ensayos clínicos sobre diabetes, los Estándares de Atención son el estándar de oro para los profesionales en el campo médico e incluyen pautas de práctica nuevas y actualizadas vitales para la atención de personas con diabetes y prediabetes. "Reconocemos que los proveedores de atención médica de todo el mundo consultan nuestros Estándares de Atención para consultar lo

On July 1, 2020 Dr. Gabbay will begin his tenure at the American Diabetes Association ® The American Diabetes Association (ADA) is pleased to announce that Robert A. Gabbay, MD, PhD has been named Chief Scientific & Medical Officer (CSMO). Dr. Gabbay is internationally renowned and brings vast knowledge in diabetes clinical care and management, innovative research and thought leadership to the ADA’s executive team. Since 2014, Dr. Gabbay has served as the Chief Medical Officer and Senior Vice President at Joslin Diabetes Center, and Associate Professor at Harvard Medical School. He oversaw the

In a study measuring Beta-cell (β-cell) function in adults with impaired glucose tolerance (IGT) or newly diagnosed type 2 diabetes (T2D), researchers from the Restoring Insulin Secretion (RISE) Adult Medication Study found β-cell function was improved during active treatment but did not produce any lasting benefits after treatment cessation. Results presented today at a symposium at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® suggest continued intervention may be required to alter progressive β-cell dysfunction. Given the increased recognition of the critical role

Randall has been living with Type 1 diabetes since he was 10 years old and is based in Texas. He enjoys photography and loves to spread awareness of diabetes and connect with people across the country. As the father of a child with Type 1 diabetes, advocacy takes on a whole new meaning.

Danielle has been living with type 2 diabetes for seven years. She’s written two books to empower and educate others living with diabetes. This is her story: Hello, my name is Danielle, and I'm a type 2 diabetic. I was first diagnosed back in 2013, and I instantly went into denial because I could not believe I was a diabetic. I instantly stereotyped what and who I should be as someone with diabetes. I was in denial for a very long time, but when my first symptom showed up, I took control of my life and became a fighting machine against this disease. I became an author with my first book, Let

Learn your risk for diabetes-related eye disease and diabetes. Take the Diabetes-Related Retinopathy Retina Risk test and Diabetes Risk Test using the links listed on the page.

Keith has been living with Type 1 diabetes for 6 decades. In his free time, he enjoys reading, walking and traveling.

I was 19 months old when I was diagnosed with type 1 diabetes. Living in a small rural town in South Carolina, the medical knowledge for juvenile diabetes was not progressive, so my mother moved north to the Washington, DC, area to bring me to an advanced endocrinologist who specialized in juvenile diabetes. It was determined that my onset of diabetes was from a viral infection. Here I am, 58 years of age, living with other onsets from diabetes like heart disease, hypothyroidism, kidney disease, diabetic retinopathy, neuropathy, and GERD to say the least. I've been using the Tandem t:Slim